Mechanism of autophagy induction and role of autophagy in antagonizing mitomycin C-induced cell apoptosis in silibinin treated human melanoma A375-S2 cells

被引:29
作者
Jiang, Yuan-yuan [1 ]
Yang, Ri [1 ]
Wang, Hong-jun [1 ]
Huang, Huai [1 ]
Wu, Di [1 ]
Tashiro, Shin-ichi [2 ]
Onodera, Satoshi [2 ]
Ikejima, Takashi [1 ]
机构
[1] Shenyang Pharmaceut Univ, China Japan Res Inst Med Pharmaceut Sci, Shenyang 110016, Peoples R China
[2] Showa Pharmaceut Univ, Dept Clin & Biomed Sci, Tokyo 1948543, Japan
关键词
Silibinin; Autophagy; p53; NF-kappa B; A375-S2; cell; NF-KAPPA-B; TOLL-LIKE RECEPTORS; CANCER MCF-7 CELLS; SUPPRESSION; INHIBITION; ACTIVATION; P53; PATHWAY; DEATH; YEAST;
D O I
10.1016/j.ejphar.2010.12.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to elucidate the molecular mechanisms mediating silibinin-induced autophagy in A375-S2 cells. In the present study it was found that silibinin-induced autophagy through increasing the conversion of LC3 I to LC3 II and up-regulating Beclin-1 expression, which was concomitant with p53 suppression and NF-kappa B activation. P53 inhibitor, pifithrin-alpha (PFT-alpha), increased autophagy and enhanced the expression of NF-kappa B. Moreover, inducing p53 accumulation with MG132 reduced autophagic ratio, and repressed the expression and activation of NF-kappa B expression. NF-kappa B inhibitor, pyrrolidine dithiocarbamate (PDTC) suppressed autophagy. Autophagic specific inhibitor 3-methyladenine (3-MA) treatment reversed silibinin-induced p53 suppression as well as NF-kappa B activation, suggesting that there was a positive feedback loop between p53 inhibition-mediated NF-kappa B activation and autophagy. In addition, we also found that 3-MA efficiently abrogated silibinin's cyto-protective effect against mitomycin C-induced cell death, and reversed the suppressive efficacy of silibinin on p53 expression, suggesting that autophagy contributed to silibinin's cyto-protective effect against mitomycin C-induced cell death in A375-S2 cells. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 28 条
[1]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[2]   Autophagy signaling and the cogwheels of cancer [J].
Botti, Joelle ;
Djavaheri-Mergny, Mojgan ;
Pilatte, Yannick ;
Codogno, Patrice .
AUTOPHAGY, 2006, 2 (02) :67-73
[3]  
CHEN SN, 2010, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBCAN.1010.07.003
[4]   ERK and JNK mediate TNFα-induced p53 activation in apoptotic and autophagic L929 cell death [J].
Cheng, Yan ;
Qiu, Feng ;
Tashiro, Shin-ichi ;
Onodera, Satoshi ;
Ikejima, Takashi .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (03) :483-488
[5]   Molecular biology of inflammation and sepsis: A primer [J].
Cinel, Ismail ;
Opal, Steven M. .
CRITICAL CARE MEDICINE, 2009, 37 (01) :291-304
[6]   Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy [J].
Davids, Lester M. ;
Kleemann, Britta ;
Cooper, Susan ;
Kidson, Susan H. .
CELL BIOLOGY INTERNATIONAL, 2009, 33 (10) :1065-1072
[7]   Milk thistle and prostate cancer:: Differential effects of pure flavonolignans from Silybum marianum on anti proliferative end points in human prostate carcinoma cells [J].
Davis-Searles, PR ;
Nakanishi, Y ;
Kim, NC ;
Graf, TN ;
Oberlies, NH ;
Wani, MC ;
Wall, ME ;
Agarwal, R ;
Kroll, DJ .
CANCER RESEARCH, 2005, 65 (10) :4448-4457
[8]   Toll-like receptors in control of immunological autophagy [J].
Delgado, M. A. ;
Deretic, V. .
CELL DEATH AND DIFFERENTIATION, 2009, 16 (07) :976-983
[9]   Toll-like receptors control autophagy [J].
Delgado, Monica A. ;
Elmaoued, Rasha A. ;
Davis, Alexander S. ;
Kyei, George ;
Deretic, Vojo .
EMBO JOURNAL, 2008, 27 (07) :1110-1121
[10]   The Protective Effect of Silibinin Against Mitomycin C-Induced Intrinsic Apoptosis in Human Melanoma A375-S2 Cells [J].
Jiang, Yuan-yuan ;
Wang, Hong-jun ;
Wang, Jing ;
Tashiro, Shin-ichi ;
Onodera, Satoshi ;
Ikejima, Takashi .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 111 (02) :137-146